Xvivo Perfusion Logo

Xvivo Perfusion

Develops ex-vivo machine perfusion systems to improve organ viability for transplantation.

XVIVO | ST

Overview

Corporate Details

ISIN(s):
SE0004840718 (+1 more)
LEI:
549300G2464FYLS14B41
Country:
Sweden
Address:
Gemenskapens Gata 9, 431 53 Mölndal
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Xvivo Perfusion is a medical technology company specializing in solutions for ex-vivo organ preservation. The company develops and markets innovative systems, solutions, and services that enable clinicians and researchers to preserve, assess, and transport donated organs—including lungs, hearts, livers, and kidneys—outside the body prior to transplantation. Its core offering is centered on machine perfusion technology, which aims to increase the availability and improve the quality of viable organs. Key products include the XPS™ (Ex Vivo Lung Perfusion System), Liver Assist™, and Kidney Assist Transport™, as well as the PERFADEX® Plus preservation solution. Xvivo's technologies are designed to extend organ preservation time, enhance assessment, and ultimately improve transplant outcomes, addressing the global shortage of transplantable organs.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-08 10:01
Major Shareholding Notification
Swedish 9.5 KB
2025-07-28 22:10
Legal Proceedings Report
Fördröjning i CE-godkännandeprocessen för XVIVOs perfusionslösning för hjärtpre…
Swedish 64.3 KB
2025-07-28 22:10
Legal Proceedings Report
Delay in CE approval for XVIVO’s perfusion solution for heart preservation
English 63.6 KB
2025-07-11 07:30
Interim Report
Swedish 2.0 MB
2025-07-11 07:30
Interim Report
English 2.0 MB
2025-04-25 14:25
Post-Annual General Meeting Information
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
Swedish 59.6 KB
2025-04-25 14:25
Post-Annual General Meeting Information
Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)
English 60.1 KB
2025-04-24 07:30
Quarterly Report
Swedish 1.9 MB
2025-04-24 07:30
Interim Report
English 6.8 MB
2025-03-20 17:45
Pre-Annual General Meeting Information
Notice to attend the annual general meeting in XVIVO Perfusion AB (publ)
English 111.0 KB
2025-03-20 17:45
Pre-Annual General Meeting Information
Kallelse till årsstämma i XVIVO Perfusion AB (publ)
Swedish 108.6 KB
2025-01-28 07:30
Earnings Release
Swedish 1.2 MB
2025-01-28 07:30
Annual / Quarterly Financial Statement
English 1.2 MB
2024-12-02 10:46
Major Shareholding Notification
Swedish 8.3 KB
2024-10-24 07:30
Quarterly Report
Swedish 1.2 MB

Automate Your Workflow. Get a real-time feed of all Xvivo Perfusion filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Xvivo Perfusion via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-04-28 Lena Hagman Other Buy 1,500 466,500.00 SEK
2024-11-25 Christoffer Björn Rosenblad Other Sell 2,000 915,000.00 SEK
2024-02-29 Kristoffer Nordström Other Buy 335 88,440.00 SEK
2023-11-14 Gösta Johannesson Other Buy 500 124,500.00 SEK
2023-04-24 Lars Henriksson Other Buy 400 107,200.00 SEK
2022-11-02 Gösta Johannesson Other Buy 200 34,000.00 SEK
2022-11-01 Gösta Johannesson Other Buy 1,000 166,500.00 SEK
2022-08-19 Dag Andersson Tilk Other Buy 499 99,700.20 SEK
2022-05-24 Dag Andersson Tilk Other Other 5,417 1,115,251.96 SEK
2022-05-24 Christoffer Björn Rosenblad Other Other 2,708 557,523.04 SEK

Peer Companies

Company Country Ticker View
RootLoc Co., Ltd. Logo
Develops and sells orthopedic solutions like artificial joints and spinal implants globally.
South Korea 253610
RUA LIFE SCIENCES PLC Logo
Develops and licenses implantable polymer tech and provides contract manufacturing services.
United Kingdom RUA
S2Medical AB Logo
Develops advanced wound healing and infection control solutions for burns and chronic wounds.
Sweden S2M
Safe S.A. Logo
Appears to operate in the orthopedics sector; specific details are unavailable.
France ALSAF
Safilo Group Logo
Designs, manufactures, and distributes sunglasses, optical frames, and sports eyewear globally.
Italy SFL
Scandinavian ChemoTech AB Logo
Develops electroporation tech to enhance chemotherapy for cancer, targeting Asia & the Middle East.
Sweden CMOTEC
Scandinavian Real Heart AB Logo
Develops a total artificial heart that mimics natural heart function for heart failure patients.
Sweden HEART
Schott Pharma Logo
Drug containment & delivery systems (syringes, vials) for the global pharma/biotech industry.
Germany 1SXP
Scope Fluidics S.A. Logo
Biotech venture builder creating microfluidic diagnostic systems for healthcare.
Poland SCP
Sedana Medical Logo
Develops inhaled sedation technology for mechanically ventilated patients in intensive care.
Sweden SEDANA

Talk to a Data Expert

Have a question? We'll get back to you promptly.